PRIMARYS Study group[Corporate Author] - Search Results

Your saved search

Your RSS Feed

Year	Number of Results
2016	1
2017	1
2018	1
2020	1
2025	0

Page 1

Did you mean primary study group[Corporate Author] (1 results)?

Glucose and lipid levels with lanreotide autogel 120 mg in treatment-naïve patients with acromegaly: data from the PRIMARYS study.

Caron PJ, Petersenn S, Houchard A, Sert C, Bevan JS; PRIMARYS Study Group. Caron PJ, et al. Clin Endocrinol (Oxf). 2017 Apr;86(4):541-551. doi: 10.1111/cen.13285. Epub 2016 Dec 27. Clin Endocrinol (Oxf). 2017. PMID: 27874199 Clinical Trial.

Predictive factors for responses to primary medical treatment with lanreotide autogel 120 mg in acromegaly: post hoc analyses from the PRIMARYS study.

Petersenn S, Houchard A, Sert C, Caron PJ; PRIMARYS Study Group. Petersenn S, et al. Pituitary. 2020 Apr;23(2):171-181. doi: 10.1007/s11102-019-01020-3. Pituitary. 2020. PMID: 31879842 Free PMC article. Clinical Trial.

MRI T2 signal intensity and tumor response in patients with GH-secreting pituitary macroadenoma: PRIMARYS post-hoc analysis.

Bonneville F, Rivière LD, Petersenn S, Bevan J, Houchard A, Sert C, Caron PJ; PRIMARYS Study group. Bonneville F, et al. Eur J Endocrinol. 2018 Dec 1:EJE-18-0254.R2. doi: 10.1530/EJE-18-0254. Online ahead of print. Eur J Endocrinol. 2018. PMID: 30540560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year